治疗药物-话题@MedSci

#治疗药物#

300篇内容 | 1921人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1921867, encodeId=0f0a192186e42, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=日本盐野义口服新冠病毒治疗药物Ensitrelvir（S-217622），治愈率达100%, objectType=article, longId=300218, objectId=1bf230021814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf230021814, replyNumber=0, likeNumber=44, createdTime=2022-06-01, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf230021814, moduleTitle=日本盐野义口服新冠病毒治疗药物Ensitrelvir（S-217622），治愈率达100%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bf230021814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921866, encodeId=42321921866be, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Sci Adv：1,6-二磷酸果糖可能成为自然流产的治疗药物, objectType=article, longId=299881, objectId=6b452998810c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b452998810c, replyNumber=0, likeNumber=53, createdTime=2022-12-23, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b452998810c, moduleTitle=Sci Adv：1,6-二磷酸果糖可能成为自然流产的治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b452998810c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921859, encodeId=6aaa192185997, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=JAMA：积极治疗药物监测（TDM）可提高英夫利昔单抗维持治疗期间疾病控制率，降低恶化风险, objectType=article, longId=292569, objectId=4d5629256907, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d5629256907, replyNumber=0, likeNumber=43, createdTime=2022-09-23, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d5629256907, moduleTitle=JAMA：积极治疗药物监测（TDM）可提高英夫利昔单抗维持治疗期间疾病控制率，降低恶化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d5629256907)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921865, encodeId=8c17192186591, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=复盘新冠时代，那些不得不说的突破性治疗药物, objectType=article, longId=299025, objectId=9a0f299025e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0f299025e0, replyNumber=0, likeNumber=36, createdTime=2022-06-08, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0f299025e0, moduleTitle=复盘新冠时代，那些不得不说的突破性治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a0f299025e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921868, encodeId=10e819218685a, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle= 婴儿型庞贝氏病AAV基因治疗药物获IND受理, objectType=article, longId=301101, objectId=45273011018f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45273011018f, replyNumber=0, likeNumber=40, createdTime=2022-03-26, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45273011018f, moduleTitle= 婴儿型庞贝氏病AAV基因治疗药物获IND受理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45273011018f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921861, encodeId=bc1a192186116, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=肺癌，靶向及免疫治疗药物汇总表(2022年1月), objectType=article, longId=293345, objectId=2a592933457e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a592933457e, replyNumber=0, likeNumber=49, createdTime=2022-01-10, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a592933457e, moduleTitle=肺癌，靶向及免疫治疗药物汇总表(2022年1月), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a592933457e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921879, encodeId=cf8119218e9c4, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=柳叶刀子刊：揭示亚洲首个血友病基因治疗药物临床研究成果, objectType=article, longId=728350, objectId=1f22e2835073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f22e2835073, replyNumber=0, likeNumber=41, createdTime=2023-03-01, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f22e2835073, moduleTitle=柳叶刀子刊：揭示亚洲首个血友病基因治疗药物临床研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f22e2835073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921842, encodeId=99861921842ef, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Personalis, Inc.新发表的数据显示，新型复合生物标志物NEOPS™可用于预测晚期黑色素瘤患者对癌症免疫治疗药物的应答, objectType=article, longId=215238, objectId=cb2d215238b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2d215238b4, replyNumber=0, likeNumber=37, createdTime=2022-03-19, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2d215238b4, moduleTitle=Personalis, Inc.新发表的数据显示，新型复合生物标志物NEOPS™可用于预测晚期黑色素瘤患者对癌症免疫治疗药物的应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2d215238b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921845, encodeId=778319218457b, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=一文总结睾酮替代治疗药物, objectType=article, longId=217023, objectId=5bb021e0235d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bb021e0235d, replyNumber=0, likeNumber=43, createdTime=2022-08-13, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bb021e0235d, moduleTitle=一文总结睾酮替代治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bb021e0235d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921875, encodeId=9c2319218e5d4, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=IOVS：白内障创新治疗药物初步显示出积极结果, objectType=article, longId=727589, objectId=c7b4e275890f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7b4e275890f, replyNumber=0, likeNumber=61, createdTime=2023-04-08, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7b4e275890f, moduleTitle=IOVS：白内障创新治疗药物初步显示出积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7b4e275890f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921854, encodeId=a85219218542e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=辉凌在ACG 2021上呈报基于微生物群的在研活体生物治疗药物RBX2660获奖的真实世界转归分析, objectType=article, longId=219338, objectId=3964219338c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3964219338c1, replyNumber=0, likeNumber=45, createdTime=2022-01-29, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3964219338c1, moduleTitle=辉凌在ACG 2021上呈报基于微生物群的在研活体生物治疗药物RBX2660获奖的真实世界转归分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3964219338c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921852, encodeId=72381921852b4, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=2021年10月16日简报：张文宏认为新冠疫苗接种目标是预防和降低重症；未来几周，更多新冠治疗药物将批量问世；多国选择“与新冠共存”政策；全球共有超过50个国家和地区确认接种科兴疫苗的旅行者可入境，71个国家接受国药疫苗接种者入境, objectType=article, longId=218705, objectId=308a218e0534, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=308a218e0534, replyNumber=0, likeNumber=33, createdTime=2022-09-10, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=308a218e0534, moduleTitle=2021年10月16日简报：张文宏认为新冠疫苗接种目标是预防和降低重症；未来几周，更多新冠治疗药物将批量问世；多国选择“与新冠共存”政策；全球共有超过50个国家和地区确认接种科兴疫苗的旅行者可入境，71个国家接受国药疫苗接种者入境, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=308a218e0534)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921839, encodeId=80461921839d9, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=14种房颤治疗药物如何用？来看指南全面整理！, objectType=article, longId=215024, objectId=673f21502423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=673f21502423, replyNumber=0, likeNumber=41, createdTime=2022-06-20, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=673f21502423, moduleTitle=14种房颤治疗药物如何用？来看指南全面整理！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=673f21502423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921834, encodeId=f03e1921834ec, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=国内结直肠癌一线免疫治疗药物获批，国内PD-1竞争加剧, objectType=article, longId=212815, objectId=76fd21281501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76fd21281501, replyNumber=0, likeNumber=40, createdTime=2021-09-08, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76fd21281501, moduleTitle=国内结直肠癌一线免疫治疗药物获批，国内PD-1竞争加剧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76fd21281501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921856, encodeId=36ed192185616, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据, objectType=article, longId=220575, objectId=ad652205e545, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad652205e545, replyNumber=0, likeNumber=45, createdTime=2021-12-25, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad652205e545, moduleTitle=Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad652205e545)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921835, encodeId=9fa719218359d, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=勃林格殷格翰同类首创在研免疫新药Spesolimab获得CDE突破性治疗药物认定, objectType=article, longId=213247, objectId=3f8321324e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f8321324e7a, replyNumber=0, likeNumber=27, createdTime=2022-02-26, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f8321324e7a, moduleTitle=勃林格殷格翰同类首创在研免疫新药Spesolimab获得CDE突破性治疗药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f8321324e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921830, encodeId=47391921830aa, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=FDA：氯胺酮或是真正有效的抑郁症新治疗药物？, objectType=article, longId=210695, objectId=315d2106955e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=315d2106955e, replyNumber=0, likeNumber=39, createdTime=2022-01-29, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=315d2106955e, moduleTitle=FDA：氯胺酮或是真正有效的抑郁症新治疗药物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=315d2106955e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921844, encodeId=bca819218446b, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=综述：特发性肺纤维化治疗药物治疗进展, objectType=article, longId=216060, objectId=d14f21606025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d14f21606025, replyNumber=0, likeNumber=50, createdTime=2022-01-31, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d14f21606025, moduleTitle=综述：特发性肺纤维化治疗药物治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d14f21606025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921829, encodeId=5e501921829b1, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=中重度斑块型银屑病治疗药物依奇珠单抗临床III期研究(RHBH)中国人群取得积极主要研究结果, objectType=article, longId=210549, objectId=10c5210549d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10c5210549d6, replyNumber=0, likeNumber=45, createdTime=2021-08-29, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10c5210549d6, moduleTitle=中重度斑块型银屑病治疗药物依奇珠单抗临床III期研究(RHBH)中国人群取得积极主要研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10c5210549d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921847, encodeId=f762192184e1f, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=J Clin Oncol：选择乳腺癌内分泌治疗药物，要注意什么？, objectType=article, longId=217715, objectId=298721e71540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=298721e71540, replyNumber=0, likeNumber=43, createdTime=2022-05-19, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=298721e71540, moduleTitle=J Clin Oncol：选择乳腺癌内分泌治疗药物，要注意什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=298721e71540)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗药物

2020-05-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

日本盐野义口服新冠病毒治疗药物Ensitrelvir（S-217622），治愈率达100%

2022-06-01

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Sci Adv：1,6-二磷酸果糖可能成为自然流产的治疗药物

2022-12-23

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

JAMA：积极治疗药物监测（TDM）可提高英夫利昔单抗维持治疗期间疾病控制率，降低恶化风险

2022-09-23

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

复盘新冠时代，那些不得不说的突破性治疗药物

2022-06-08

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

婴儿型庞贝氏病AAV基因治疗药物获IND受理

2022-03-26

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

肺癌，靶向及免疫治疗药物汇总表(2022年1月)

2022-01-10

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

柳叶刀子刊：揭示亚洲首个血友病基因治疗药物临床研究成果

2023-03-01

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Personalis, Inc.新发表的数据显示，新型复合生物标志物NEOPS™可用于预测晚期黑色素瘤患者对癌症免疫治疗药物的应答

2022-03-19

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

一文总结睾酮替代治疗药物

2022-08-13

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

IOVS：白内障创新治疗药物初步显示出积极结果

2023-04-08

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

辉凌在ACG 2021上呈报基于微生物群的在研活体生物治疗药物RBX2660获奖的真实世界转归分析

2022-01-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

2021年10月16日简报：张文宏认为新冠疫苗接种目标是预防和降低重症；未来几周，更多新冠治疗药物将批量问世；多国选择“与新冠共存”政策；全球共有超过50个国家和地区确认接种科兴疫苗的旅行者可入境，71个国家接受国药疫苗接种者入境

2022-09-10

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

14种房颤治疗药物如何用？来看指南全面整理！

2022-06-20

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

国内结直肠癌一线免疫治疗药物获批，国内PD-1竞争加剧

2021-09-08

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据

2021-12-25

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

勃林格殷格翰同类首创在研免疫新药Spesolimab获得CDE突破性治疗药物认定

2022-02-26

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

FDA：氯胺酮或是真正有效的抑郁症新治疗药物？

2022-01-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

综述：特发性肺纤维化治疗药物治疗进展

2022-01-31

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

中重度斑块型银屑病治疗药物依奇珠单抗临床III期研究(RHBH)中国人群取得积极主要研究结果

2021-08-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

J Clin Oncol：选择乳腺癌内分泌治疗药物，要注意什么？

2022-05-19

科室
- - 订阅+
  - 更多科室
工具
服务